ROCHE I/ CH0012032113 /
10/3/2023 5:30:13 PM | Chg. -0.80 | Volume | Bid5:40:00 PM | Ask5:40:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
264.40CHF | -0.30% | 22,085 Turnover: 5.84 mill. |
263.00Bid Size: 148 | 280.00Ask Size: 12 | 201.29 bill.CHF | 3.59% | 17.04 |
Newsfile Corp
9/6
First Phosphate Corp. obtient des résultats positifs pour la production pilote d'acide phosphorique ...
Newsfile Corp
3/31
Reuters IMPACT in September with C-suits from NatWest, Roche, CalPERS, Bezos Earth Fund and More
GlobeNewswire
1/12/2022
Mainz Biomed Appoints Michele Pedrocchi, Former Head of Roche Diagnostics Business Development, to S...
GlobeNewswire
12/17/2021
Spark Therapeutics to Invest $575M in New 500k Square Foot State-of-the-Art Gene Therapy Innovation ...
Newsfile Corp
11/23/2021
Innovative Medicines Canada and Roche Canada Announce Scholarship for the University of Toronto's Da...
GlobeNewswire
11/11/2021
Mainz Biomed Appoints Former Roche Division President Heiner Dreismann to Strategic Advisory Board
GlobeNewswire
9/29/2021
Innovaccer Announces Collaboration with Roche to Develop Clinical Decision Support and Workflow Solu...
GlobeNewswire
9/1/2021
Else Nutrition to Expand into Roche Bros. with Plant-Based Complete Toddler Nutrition